aTyr Pharma initiates phase Ib/IIa study of ATYR-1923 in patients with pulmonary sarcoidosis Dec. 5, 2018 No Comments
Vertex reports phase III data on VX-659 triple combination regimen for cystic fibrosis Nov. 28, 2018 No Comments
Phase III study of VR-475 in severe uncontrolled asthma does not meet primary endpoint Nov. 26, 2018 No Comments
RSS